UPDATE : Friday, June 5, 2020
상단여백
'Pharmacovigilance as crucial as clinical trials'
The importance of pharmacovigilance, which is the task of collecting and an...
by Lee Han-soo  |  2019-10-24 18:21
라인
Daewoong releases trial data on gastroesophageal reflux disease drug
Daewoong Pharmaceutical said that it has presented its phase 1 multiracial ...
by Lee Han-soo  |  2019-10-24 17:00
라인
Novartis’ Cosentyx strengthens position as comprehensive psoriasis treatment
Novartis said it presented the long-term real-world evidence data for Cosen...
by Lee Han-soo  |  2019-10-24 14:47
라인
AbbVie draws favorable rating for its rheumatism drug in Europe
AbbVie Korea said the European Medicines Agency's Committee for Medicin...
by Lee Han-soo  |  2019-10-24 14:45
라인
PharmAbcine sets up US unit to develop anticancer drug
PharmAbcine said it would speed up the development of a new anticancer drug...
by Jeong Sae-im  |  2019-10-23 15:48
라인
Pfizer Korea reaffirms corporate missions on 50th anniversary
Under the corporate slogan of “breakthroughs that change patients' live...
by Lee Han-soo  |  2019-10-23 14:53
라인
Gemvax & Kael's GV1001 shows efficacy as prostate cancer treatment
Gemvax & Kael said that it has confirmed the efficacy of GV1001 in treating...
by Lee Han-soo  |  2019-10-23 10:59
라인
Pfizer’s atopic drug should overcome side effects to challenge Sanofi’s Dupixent
Pfizer recently proved the efficacy of its investigational atopic dermatiti...
by Kim Yun-mi  |  2019-10-22 14:17
라인
Pharma industry hits government steps regarding ranitidine ban
The local pharmaceutical industry is expressing its distrust and displeasur...
by Lee Han-soo  |  2019-10-21 17:16
라인
Dong-A ST leaves KPBMA to ‘repent of illegal rebate’
Dong-A ST is voluntarily giving up its membership of the Korea Pharmaceutic...
by Jeong Sae-im  |  2019-10-21 16:42
라인
GSK applies for additional indication of asthma inhaler Trelegy Ellipta
GSK said that it has applied to obtain an additional indication for Trelegy...
by Lee Han-soo  |  2019-10-21 15:32
라인
Drug firms’ Q3 earnings to be fairly good
Korea’s large pharmaceutical companies are expected to have yielded good ea...
by Jeong Sae-im  |  2019-10-21 12:27
라인
Regulator OKs Jeil's advanced colorectal cancer treatment
Jeil Pharmaceutical said that the Ministry of Food and Drug Safety has appr...
by Lee Han-soo  |  2019-10-21 11:38
라인
Ministry OKs ATGC's p1, 2 trial for BTX
ATGC, a local biopharmaceutical firm, said that the Ministry of Food and Dr...
by Lee Han-soo  |  2019-10-18 18:23
라인
Physicians feel burdened by Ranitidine ban: survey
Nearly half of doctors have encountered difficulties with patients over the...
by Lee Han-soo  |  2019-10-18 16:48
라인
Daewoong launches BTX in Canada
Daewoong Pharmaceutical said that it has launched its botulinum toxin (BTX)...
by Lee Han-soo  |  2019-10-18 14:31
라인
CHA Biotech wins patent for somatic-cloned embryonic stem cell tech
CHA Biotech said it has registered a patent for the method of manufacturing...
by Lee Han-soo  |  2019-10-17 17:59
라인
US sales of Remicade drop due to biosimilar’s rise
U.S. sales of Remicade (ingredient: infliximab), the autoimmune disease tre...
by Jeong Sae-im  |  2019-10-17 13:32
라인
'Eisai's Lenvima extends survival period, improves patients’ quality of life'
Eisai's Lenvima, a hepatocellular carcinoma treatment, has managed to s...
by Lee Han-soo  |  2019-10-16 18:22
라인
‘New drug approval process takes about 300 days in Korea’
A local research team has found that it takes about 300 days for multinatio...
by Lee Han-soo  |  2019-10-16 15:06
여백
여백
여백
Back to Top